Although KLRG1 levels were lower on T cells in tumors compared with blood, a proportion of T cells maintained KLRG1 expression in tumors (Figure 4D and Figure 7C) and can still be inhibited by tumor E-cadherin. This evidence concerns the gene CDH1 and neoplasm.